A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
Status:
Completed
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if Symbicort (budesonide/formoterol) Turbuhaler is
effective in treating asthma when used 'as needed' in patients with milder asthma. The
efficacy of Symbicort 'as needed' will be compared with Pulmicort (budesonide) Turbuhaler
twice daily plus terbutaline Turbuhaler 'as needed'
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Terbutaline